Brain tumors and brain metastasis of tumors are very difficult clinical situations. Brain tumors, represented by glioma, are one of the most difficult cancers to overcome at present. Even some brain tumors still have no effective treatment and the existing treatment pathways are largely unable to prevent a recurrence. Antibody-engineered drugs, which are the fastest growing in the field of biomedicine, have brought new light to the treatment of brain tumors.
Antibody drug development services for brain tumors
Antibody-mediated immunotherapy is an important tool for immunotherapy of brain tumors, in addition to ICI, cancer vaccines, pericyte therapy, and lysing virus therapy. Alfa Cytology aims to provide our clients with antibody development services for brain tumors through our proven technology platform. These include PD-1/PD-L1 antibodies for immune checkpoint inhibitors, antibodies that inhibit the CD161-CLEC2D pathway, and 124I-8H9 monoclonal antibodies targeting B7-H3.
Learn moreļ¼brain tumor antibody drug development services
Share this page with your family and friends.